Joe Flores-Toro, one of our very own graduate students, had his abstract accepted for the ASPET Division for Cancer Pharmacology Young Investigators Symposium. His abstract was also one of ten from each host society chosen to be featured early at the welcome reception for the event.
His abstract is titled, “CCR2 Inhibition Reduces Tumor-Associated Myeloid-Derived Suppressor Cells and Unmasks an α-PD-1 Effect to Slow Tumor Progression in Checkpoint Inhibitor Resistant Gliomas.”
According to the ASPET website, the ASPET Annual Meeting is where pharmacology meets experimental biology in one community:
“Join 1600 scientists passionate about pharmacology as ASPET intersects with over 10,000 other experimental biologists in physiology, biochemistry, molecular biology, pathology, and anatomy. The ASPET program includes a wide variety of scientific symposia with invited and abstract-based speakers, award-winning lecturers, poster sessions, division-focused sessions, education and career development sessions, a student and postdoc poster competition and numerous mixers and networking events.”
This event will be held in Orlando, Florida, for 2019. The symposium is on Tuesday, April 9, from 4 p.m. to 6 p.m., and the welcome reception is Saturday, April 6, from 7 p.m. to 8:30 p.m.
In addition to this prestigious event, Flores-Toro was also recently chosen for the ASPET Washington Fellows Program, where “fellows will develop an understanding of how public policy decisions made in Washington, D.C. help shape and impact science policy, such as funding for the National Institutes of Health and other science agencies.”
Congratulations, Joe!
